#1 prescribed branded treatment for migraine attacks

As of 12/23.1,2




Eliminates pain1

Powerful results

21% of patients experienced pain freedom at 2 hours (co-primary endpoint)*

UBRELVY® 100 mg (95/448) vs 12% placebo (54/456)1,3


Relieves pain quickly1

Rapid results

61% of patients experienced pain relief at 2 hours (secondary endpoint)*

UBRELVY 100 mg (275/448) vs 49% placebo (224/456)1,4


Demonstrated data for treatment early in the migraine attack5

Prodrome data

Data on patients who avoided moderate to severe headache pain, when UBRELVY 100 mg was taken during prodrome5

Data presented above is in reference to UBRELVY 100 mg only. See similar results for patients taking UBRELVY 50 mg.6

See ACHIEVE Pivotal Trials Design pop-up for more detail, including additional co-primary endpoint data.


UBRELVY® (ubrogepant) is indicated for the acute treatment of migraine with or without aura in adults. UBRELVY is not indicated for the preventive treatment of migraine.

$0 savings card

Comprehensive Savings and Support

With the UBRELVY Complete Savings Card, eligible commercially insured patients may pay as little as $0 a month for UBRELVY

UBRELVY Challenge logo

For Eligible Commercially Insured Patients Taking an Oral Triptan

Start your patients on UBRELVY with the UBRELVY Challenge. If they choose to refill their oral triptan, the next triptan fill is on us

UBRELVY is covered for 94% of national commercially insured lives.

Broad National Coverage

UBRELVY is covered for 94% of nationally commercially insured lives

*In pivotal clinical studies, patients took UBRELVY within 4 hours of a migraine attack.7

Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit or call 1-844-577-6239 for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit

Offer not available to patients enrolled in Medicare, Medicaid, or any other federal or state healthcare programs. Restrictions, including savings maximums, apply. Patient out-of-pocket expense will vary depending on insurance coverage. UBRELVY coupon becomes valid upon activation of offer. Oral triptan medication coupon becomes valid two (2) weeks from activation of offer and expires six (6) weeks from activation of offer. For full Terms and Conditions, visit or call 1-844-577-6239 for more information.

§Source: Data on file as of January, 2024. Data subject to change. Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits are determined by respective plan administrators, insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurer. AbbVie does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.


No head-to-head studies have been conducted between UBRELVY and triptans; therefore, no conclusions regarding safety or efficacy can be drawn.